⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29545376 | 0.98 | — | — | |
| SCHEMBL846820 | 0.73 | — | — | |
| SCHEMBL27536094 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL26094262 | 0.71 | CHRNB4 (0.32) | — | |
| SCHEMBL1121705 | 0.70 | — | — | |
| SCHEMBL31378625 | 0.68 | — | — | |
| SCHEMBL27582224 | 0.68 | — | — | |
| SCHEMBL29196134 | 0.66 | CYP1A2 (0.30) | — | |
| SCHEMBL16339613 | 0.66 | — | — | |
| SCHEMBL3993569 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250338712-A1 | LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND | SAMSUNG DISPLAY CO LTD (KR) | 2025-10-30 | — | — | US | claimed |
| CN-119954965-A | EBV vaccine comprising gp350 polypeptide variant, and preparation method and application thereof | 北京吉诺卫生物科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119930840-A | Recombinant HPIV3-F protein nanoparticle vaccine, preparation method and application thereof | 北京吉诺卫生物科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-12005127-B2 | DNA-PK inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-06-11 | — | — | US | claimed |
| EP-3740480-B1 | DNA-PK INHIBITORS | VERTEX PHARMA (US) | 2024-03-06 | — | — | EP | claimed |
| US-11813267-B2 | DNA-PK inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-11-14 | — | — | US | claimed |
| CN-116615255-A | Polypeptides targeting SARS-CoV-2 and related compositions and methods | 儿童医院 | 2023-08-18 | — | — | CN | claimed |
| EP-3985003-B1 | DNA-PK INHIBITORS | VERTEX PHARMA (US) | 2023-08-09 | — | — | EP | claimed |
| CN-116113430-A | Coronavirus vaccine | 奎尔法克股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| EP-3985003-A1 | DNA-PK INHIBITORS | Vertex Pharmaceuticals Incorporated (US) | 2022-04-20 | — | — | EP | claimed |
| EP-1216246-A1 | N-SUBSTITUTED 4-AMINOPTERIDINES, SYNTHESIS AND USE THEREOF AS PHARMACEUTICAL AGENT | Vasopharm Biotech GmbH & Co. KG (DE) | 2002-06-26 | — | — | EP | claimed |
| WO-2001021619-A1 | N-SUBSTITUTED 4-AMINOPTERIDINES, SYNTHESIS AND USE THEREOF AS PHARMACEUTICAL AGENT | VASOPHARM BIOTECH GMBH & CO. KG (DE) | 2001-03-29 | — | — | WO | claimed |
| EP-0631581-A4 | INTERMEDIATES AND A PROCESS FOR SYNTHESIS OF TETRAHYDROPTERIDINE C6-STEREOISOMERS, INCLUDING (6S)-TETRAHYDROFOLATE AND N5-FORMYL-(6S)-TETRHYDROFOLATE. | BAILEY STEVENW (US) | 1995-08-02 | — | — | EP | claimed |
| EP-0318926-B1 | Intermediates for synthesizing 5,6,7,8-tetrahydro-L-erythro-biopterin and its derivatives | VITAMIN KENKYUSHO KK (JP) | 1995-05-03 | — | — | EP | claimed |
| EP-0631581-A1 | INTERMEDIATES AND A PROCESS FOR SYNTHESIS OF TETRAHYDROPTERIDINE C6-STEREOISOMERS, INCLUDING (6S)-TETRAHYDROFOLATE AND N5-FORMYL-(6S)-TETRHYDROFOLATE | BAILEY, StevenW. (US) | 1995-01-04 | — | — | EP | claimed |
| US-5350851-A | Intermediates and a process for synthesis of tetrahydropteridine C6-stereoisomers, including (6S)-tetrahydrofolate and N5-formyl-(6S)-tetrahydrofolate | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION (US) | 1994-09-27 | — | — | US | claimed |
| WO-1993019069-A1 | INTERMEDIATES AND A PROCESS FOR SYNTHESIS OF TETRAHYDROPTERIDINE C6-STEREOISOMERS, INCLUDING (6S)-TETRAHYDROFOLATE AND N5-FORMYL-(6S)-TETRHYDROFOLATE | BAILEY STEVEN W (US) | 1993-09-30 | — | — | WO | claimed |
| US-5198547-A | Process for N5-formylating tetrahydropteridines | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION, USA (US) | 1993-03-30 | — | — | US | claimed |
| US-4937342-A | Intermediates for synthesizing BH4 and its derivatives | KABUSHIKI KAISHA VITAMIN KENKYUSYO (JP) | 1990-06-26 | — | — | US | claimed |
| EP-0318926-A2 | Intermediates for synthesizing 5,6,7,8-tetrahydro-L-erythro-biopterin and its derivatives | Kabushiki Kaisha Vitamin Kenkyusyo (JP) | 1989-06-07 | — | — | EP | claimed |